Clin2
NCT07343024Worth exploringRecruiting

Finding a Personalized Drug for Advanced Cancer

Advanced Cancer

Part of Cancer clinical trials.

This trial looks at whether drugs not usually used for your type of cancer can help you. It matches your tumor's test results to possible treatments and works with your doctor to try one.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
Any age
Study type
Observational

Who can take part

  • You must have a genomic or functional test result that suggests a possible drug for your cancer.
  • Your doctor must agree to try a drug that is not standard treatment for your type of cancer.
  • You need a way to pay for the drug, like insurance or covering the cost yourself.
  • You must sign a consent form to take part in the trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05159245Recruiting· Phase 2
Targeted drug access for adults with advanced cancer

This trial helps match people with advanced, hard-to-treat cancers to targeted cancer drugs based on lab testing of their tumor. It may help if standard treatment isn’t working or isn’t available, and if your tumor has a “targetable” genetic change.

Turku, Southwest Finland
NCT05674825Recruiting· Phase 1/Phase 2
Personalized treatment using tumor test results for aggressive cancers

This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.

Milwaukee, Wisconsin
NCT02693535Recruiting· Phase 2
Targeted drug testing for advanced cancer with tumor gene changes

This trial tests whether FDA-approved targeted drugs can help people with advanced cancer whose tumors have specific gene changes. It aims to match your tumor's unique genetic profile to a drug that may work better for you.

Birmingham, Alabama
NCT07346209Not yet recruiting· Phase 2
Personalized cancer treatment study

This study tests whether choosing cancer treatments based on the unique genetic changes in your tumor can help people with advanced cancer live longer. You would receive FDA-approved drugs that match your tumor's specific markers.

La Jolla, California
NCT03297606Recruiting· Phase 2
Match your tumor test to a targeted cancer drug

This trial studies whether giving a targeted cancer medicine based on tumor genetic/protein test results can help people with advanced, incurable cancers live longer. You may be eligible if your cancer has a “potentially actionable” change on testing and you meet health and follow-up requirements.

Edmonton, Alberta
NCT07802418Not yet recruiting· Phase 2
Personalized treatment for advanced pancreatic cancer

This trial tests treatments that are chosen specifically for you based on the genetic makeup of your tumor. The goal is to find a targeted therapy that may work better for your advanced pancreatic cancer after standard chemotherapy has stopped being effective.

Aalborg

Hear when a new Advanced Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.